Dr S K Gupta
Best Hematologist in Hyderabad
Advanced Care!
Hematology BMT offers latest technology for blood disorders & bone marrow transplants.
15+ Years of Experience

Bone Marrow Transplant Specialist

Dr. S K Gupta, highly skilled expert in the fields of Hematology, Hemato-Oncology, and Bone Marrow Transplantation. Dr. Gupta’s practice benefits from his extensive qualifications, which include MBBS, MD, DM from AIIMS Delhi, and Fellowship in Leukemia/BMT/CAR T Cells from UBC, Canada.

With expertise in blood and bone marrow transplant, he ensures to provide state-of-the-art care and compassionate attention. If you’re looking for top-notch medical expertise, don’t hesitate to book a consultation with Dr. S K Gupta.

Hematologist in Hyderabad

Our Services


Cancer of the blood cells, leading to abnormal production of white blood cells.


Cancer originating in the lymphatic system, affecting lymphocytes, a type of white blood cell.

Bone Marrow Transplantation

Procedure involving the replacement of damaged or diseased bone marrow with healthy stem cells.

Systemic Therapies

Treatments targeting cancer cells throughout the body, including chemotherapy, immunotherapy, and targeted therapy.


 Disorder characterized by low platelet count, leading to increased risk of bleeding.

Genetic Testing & Blood Transfusion

Diagnostic techniques to identify inherited blood disorders and procedures for safe blood transfusion.

Multiple Myeloma

Cancer of plasma cells, impacting bone marrow and leading to bone damage and weakened immune function.

Blood Cancer

A general term encompassing cancers that affect the blood, bone marrow, and lymphatic system.


Condition characterized by a deficiency of red blood cells or hemoglobin, resulting in fatigue and weakness.

Coagulation & Bleeding Disorders

Conditions affecting the blood’s ability to clot properly, leading to excessive bleeding or clot formation.

Our Services include

  • Myelodysplastic Syndromes
  • Sickle Cell Disease
  • Thalassemia
  • Polycythemia Vera
  • Essential Thrombocythemia
  • Myeloproliferative Neoplasms
  • Swollen lymph nodes
  • Hemophagocytic lymphohistiocytosis (HLH)
  • Paroxysmal nocturnal hemoglobinuria (PNH)
  • Bone Marrow Transplant a/k/a Stem Cell Transplant
  • Bone Marrow Aspiration and Biopsy
  • Blood Tests (Complete Blood Count, Coagulation Studies, etc.)
  • Flow Cytometry Analysis
  • Genetic Testing for Blood Disorders
  • Chemotherapy
  • Immunotherapy
  • Targeted Therapy
  • Bone Marrow Transplantation
  • Radiation Therapy
  • Transfusion of Blood Products (Red Blood Cells, Platelets, etc.)
  • Coagulation Factor Replacement Therapy

Patient Information

Hemoglobin is a protein in red blood cells that binds to oxygen in the lungs and carries it to tissues throughout the body. It also helps transport carbon dioxide from the tissues back to the lungs for exhalation.

The CBC test is a common blood test that provides important information about the types and numbers of cells in the blood, including red blood cells, white blood cells, and platelets. It can help diagnose a variety of conditions, such as anemia, infection, inflammation, and blood disorders. The CBC results, along with other tests and clinical findings, aid in the diagnosis and monitoring of patients with hematological disorders.

 A bone marrow biopsy involves the removal of a small sample of bone marrow tissue for examination under a microscope. It is performed to diagnose various blood disorders, such as leukemia, lymphoma, anemia, and certain infections. It provides information about the composition of the bone marrow, including the types and numbers of blood cells being produced.

Common symptoms of anemia include fatigue, weakness, pale skin, shortness of breath, dizziness or lightheadedness, cold hands and feet, and headaches. Severe anemia may also cause chest pain, rapid heartbeat, and cognitive problems.

Benign hematological disorders are non-cancerous conditions that affect the blood or bone marrow, such as anemia or thrombocytopenia. Malignant hematological disorders, on the other hand, are cancers that originate from blood-forming tissues, such as leukemia, lymphoma, or multiple myeloma. Malignant disorders involve uncontrolled growth and proliferation of abnormal cells.

Risk factors for hematological cancers include genetic predisposition, exposure to certain chemicals or radiation, immune system disorders, viral infections (such as Epstein-Barr virus or human T-cell leukemia virus), and some inherited conditions (like Down syndrome or certain types of anemia).

Treatment for hematological cancers depends on the specific type and stage of the disease but may include chemotherapy, radiation therapy, targeted therapy, immunotherapy, stem cell transplantation, and/or surgery. The treatment approach is often tailored to individual patients based on factors such as age, overall health, and genetic markers.

Molecular testing, such as cytogenetic analysis and next-generation sequencing, plays a crucial role in the diagnosis, prognosis, and treatment selection for hematological cancers. It helps identify specific genetic mutations or chromosomal abnormalities that drive cancer growth, allowing for more precise treatment strategies, including targeted therapies.